AstraZeneca Wins U.S. Approval for Ultomiris in Rare Kidney Disease
AstraZeneca said Ultomiris was approved in the U.S. to treat foamy urine in adults with immunoglobulin A nephropathy, a rare condition that can lead to chronic kidney disease.
Related stories
Italy Fines Meta €805 Million Over Android Data Access
Italy’s privacy regulator fined Meta Platforms Ireland €805 million, finding it accessed photos, videos and related information stored on Android devices without specific user perm
M impact | REGULATION | Nov 14, 2026, 03:10 PM UTC
Meta fined €805 million in Italy
Meta must pay a €805 million fine in Italy, Reuters reports.
M impact | REGULATION | Nov 14, 2026, 02:44 PM UTC
US transportation sec. Duffy: flight operations gradually returning to normal this morning
L impact | REGULATION | Nov 14, 2026, 01:51 PM UTC
Italy Fines Meta €805 Million Over Android Users’ Data Access
Italy’s data protection agency said Meta accessed Android users’ photos and videos without consent or notification.
M impact | REGULATION | Nov 14, 2026, 01:04 PM UTC
Italy Fines Meta $887 Million Over Android Users' Data Access
Italy fined Meta over Android users' data access. The wire headline reports a fine of $887 million.
M impact | REGULATION | Nov 14, 2026, 01:04 PM UTC
Italy Fines Meta €805 Million Over Android User Data
Italy’s data protection agency said it fined Meta Platforms €805 million ($887 million) for allegedly accessing Android users’ photos and videos without consent or informing them.
M impact | REGULATION | Nov 14, 2026, 12:27 PM UTC